drugset / Trial / NCT06494644

A Study to Assess the Pharmacokinetics of AZD6793 When Administered Alone and in Combination With Itraconazole in Healthy Participants.

NCT06494644 ↗

Phase 1 Completed 17 enrolled AstraZeneca
NaSingle-groupOpen-labelOther

Summary

The study will evaluate the pharmacokinetics (PK) of AZD6793 when administered alone and in combination with itraconazole in healthy adult participants.

Timeline

Start
2024-07-23
Primary completion
2024-10-05
Completion
2024-10-05

Drugs

EvaluationDrugModalityDoseRoute
Subject AZD6793 Unknown — —
Subject Itraconazole Small molecule 200 mg —

Indications

No indication recorded.